Zola P Horovitz

Title: The Innovative Contributions of Zola P Horovitz

Introduction

Zola P Horovitz is a notable inventor based in Princeton, NJ, who has made significant contributions to the field of cognitive health and addiction treatment. With a total of eight patents to his name, Horovitz has focused on developing methods that address critical health issues.

Latest Patents

Among his latest patents is a method for preventing or inhibiting the loss of cognitive function, which may be associated with Alzheimer's disease. This method involves administering an ACE inhibitor, such as captopril, fosinopril, zofenopril, or ceranapril, in combination with a drug that acts on serotonin receptors, such as zacopride, over a prolonged treatment period. Another significant patent addresses the treatment of addiction to drugs of abuse, including nicotine, cocaine, or diazepam. This method aims to inhibit appetite or desire for such drugs by administering an ACE inhibitor, either alone or in combination with a calcium channel blocker like diltiazem or nifedipine, over an extended period.

Career Highlights

Zola P Horovitz is currently associated with E.R. Squibb & Sons, Inc., where he continues to innovate and contribute to the field of pharmaceuticals. His work has been instrumental in developing therapeutic methods that have the potential to improve the quality of life for many individuals.

Collaborations

Throughout his career, Horovitz has collaborated with notable colleagues, including Abraham Sudilovsky and Brenda Costall, who have contributed to his research and development efforts.

Conclusion

Zola P Horovitz's innovative work in cognitive health and addiction treatment highlights his commitment to advancing medical science. His patents reflect a deep understanding of complex health issues and a dedication to finding effective solutions.